CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 13th Annual BIO CEO & Investor Conference on Tuesday, February 15, 2011 at 1:30 p.m. ET at Waldorf-Astoria in New York City.
